News
Home > News > News
- 2022/07/28Obtained Outstanding Company of the year, 2022 Taiwan BIO awards
- 2022/05/13CCSB accomplished an inspection of Taiwan Food and Drug Administration (TFDA).
- 2022/05/10CCSB accomplished Caspofungin and Trandolapril remote audit.
- 2022/04/22CCSB accomplished Methocarbamol audit.
- 2022/03/04CCSB accomplished Tacrolimus remote audit.
- 2022/02/25CCSB accomplished Mycophenolate Mofetil remote audit.
- 2022/02/21CCSB accomplished Methocarbamol remote audit.
- 2022/01/26CCSB accomplished Caspofungin remote audit.
- 2022/01/24CCSB obtained Taiwan patent for Ethyl Icosapentate
- 2022/01/24CCSB obtained Taiwan patent for Etelcalcetide
